Pfizer said Friday that its easy-to-administer Covid-19 pill, used in combination with a widely used HIV drug, cut the risk of hospitalization or death by 89% in high-risk adults who’ve been exposed to the virus.
It’s now the second antiviral pill behind Merck‘s to demonstrate strong effectiveness for treating Covid at the first sign of illness. If cleared by regulators, it would likely be a game changer in the ongoing global pandemic fight.
Pfizer CEO Albert Bourla told CNBC the company plans to submit its data to the Food and Drug Administration before Thanksgiving.
“I think this medicine will change the way things are happening right now that will save millions and millions of lives, it has the potential to do it,” Bourla said in an interview on CNBC’s “Squawk Box.” He said the company has “the capacity right now of 500 million pills,” which he said translates to 50 million treatments. “The very high efficacy comes even to us as a surprise, exceeds our most visionary expectations we had for that.”
The company’s shares jumped by about 8% in morning trading.
WASHINGTON — John Eastman, the former Trump lawyer who wrote memos arguing then-Vice President Mike Pence could overturn the 2020 election, has dropped his lawsuit that tried to block the House Jan. 6 committee from getting his call logs. Eastman’s lawyers said in a filing in U.S. District Court for the District of Columbia on Tuesday night that…
Associated Press-Patrick Semansky In a file photo, Virginia “Ginni” Thomas, wife of Supreme Court Justice Clarence Thomas, arrives to watch Amy Coney Barrett take the Constitutional Oath on the South Lawn of the White House in Washington, Monday, Oct. 26, 2020. The attorney for Ginni Thomas, the wife of Supreme Court Justice Clarence Thomas, said…